Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Barth syndrome is a rare and potentially fatal X-linked disease characterized by cardiomyopathy, skeletal muscle weakness, growth delays, and cyclic neutropenia. Patients with Barth syndrome are prone to high risk of mortality in infancy and the development of cardiomyopathy with severe weakening of the immune system. Elamipretide is a water-solubl...
Alternative Titles
Full title
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9388406
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9388406
Other Identifiers
ISSN
1382-4147
E-ISSN
1573-7322
DOI
10.1007/s10741-021-10177-8
